Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Ernesto Sparrelid to Colorectal Neoplasms

This is a "connection" page, showing publications Ernesto Sparrelid has written about Colorectal Neoplasms.

 
Connection Strength
  
 
 
3.480
  
  1. Reese T, Björk D, Longva AMH, Kiim KS, Evers M, Larsen PN, Schultz NA, Røsok BI, Carling U, Holmquist F, Lindell G, Sandström P, Böcker J, Gilg S, Engstrand J, Sturesson C, Oldhafer KJ, Björnsson B, Sparrelid E. Oncological safety of portal vein embolization without prior tumour clearance in the future liver remnant followed by one-stage hepatectomy for bilateral colorectal liver metastases. Br J Surg. 2025 Sep 02; 112(9).
    View in: PubMed
    Score: 0.554
  2. Wang Q, Brismar TB, Gilg S, Jonas E, Nilsson H, Tzortzakakis A, Isaksson B, Axelsson R, Sparrelid E. Multimodal perioperative assessment of liver function and volume in patients undergoing hepatectomy for colorectal liver metastasis: a comparison of the indocyanine green retention test, 99mTc mebrofenin hepatobiliary scintigraphy and gadoxetic acid enhanced MRI. Br J Radiol. 2022 Oct 01; 95(1139):20220370.
    View in: PubMed
    Score: 0.452
  3. Villard C, Habib M, Nordenvall C, Nilsson PJ, Jorns C, Sparrelid E. Conversion therapy in patients with colorectal liver metastases. Eur J Surg Oncol. 2021 08; 47(8):2038-2045.
    View in: PubMed
    Score: 0.404
  4. Barimani D, Kauppila JH, Sturesson C, Sparrelid E. Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review. World J Surg Oncol. 2020 Oct 08; 18(1):264.
    View in: PubMed
    Score: 0.394
  5. Sparrelid E, Gilg S, Brismar TB, Lundell L, Isaksson B. Rescue ALPPS is efficient and safe after failed portal vein occlusion in patients with colorectal liver metastases. Langenbecks Arch Surg. 2017 Feb; 402(1):69-75.
    View in: PubMed
    Score: 0.299
  6. Sterner J, Andersson M, Olofsson A, Jansson H, Strömberg C, D'Souza M, Sturesson C, Sparrelid E, Gerling M, Gilg S, Engstrand J. Impact of post-hepatectomy liver failure on recurrence following major hepatectomy for colorectal cancer liver metastases. HPB (Oxford). 2025 Oct; 27(10):1309-1317.
    View in: PubMed
    Score: 0.137
  7. Yaqub S, Longva A, Angelsen JH, Brudvik KW, Carling U, Edwin B, Fretland ÅA, Grünhagen DJ, Line PD, Røsok BI, Smedman TM, Sparrelid E, Syversveen T, Villanger O, Lassen K. Multimodal treatment for colorectal liver metastases: A toolbox for clinicians. Scand J Surg. 2025 Jun; 114(2):126-134.
    View in: PubMed
    Score: 0.135
  8. Villard C, Abdelrafee A, Habib M, Ndegwa N, Jorns C, Sparrelid E, Allard MA, Adam R. Prediction of survival in patients with colorectal liver metastases- development and validation of a prognostic score model. Eur J Surg Oncol. 2022 Dec; 48(12):2432-2439.
    View in: PubMed
    Score: 0.111
  9. Strömberg C, Martinez de la Maza L, Fernández Moro C, Gerling M, Jorns C, Sparrelid E, Löhr MJ, Villard C. Prognostic impact of inter-metastatic heterogeneity of viable tumour cells in colorectal liver metastases. Eur J Surg Oncol. 2022 07; 48(7):1656-1663.
    View in: PubMed
    Score: 0.109
  10. Yaqub S, Bjørnbeth BA, Angelsen JH, Fristrup CW, Grønbech JE, Hemmingsson O, Isaksson B, Juel IS, Larsen PN, Lindell G, Mortensen FV, Mortensen KE, Rizell M, Sandström P, Sandvik OM, Sparrelid E, Taflin H, Taskén K. Aspirin as secondary prevention in colorectal cancer liver metastasis (ASAC trial): study protocol for a multicentre randomized placebo-controlled trial. Trials. 2021 Sep 20; 22(1):642.
    View in: PubMed
    Score: 0.105
  11. Hasselgren K, Røsok BI, Larsen PN, Sparrelid E, Lindell G, Schultz NA, Bjørnbeth BA, Isaksson B, Larsson AL, Rizell M, Björnsson B, Sandström P. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021 03 01; 273(3):442-448.
    View in: PubMed
    Score: 0.101
  12. Sandström P, Larsson AL, Björnsson B, Røsok BI, Sparrelid E, Larsen PN, Schultz NA, Björnbeth BA, Lindell G, Isaksson B, Rizell M. Response to Comment on "When Innovation Is Not Enough". Ann Surg. 2019 08; 270(2):e36-e37.
    View in: PubMed
    Score: 0.091
  13. Sandström P, Røsok BI, Sparrelid E, Lindell G, Nørgaard Larsen P, Lindhoff Larsson A, Schultz NA, Bjørnbeth BA, Isaksson B, Rizell M, Björnsson B. Response to the Comment on "Should We Have a Little More Patience With the Conventional 2-Stage Hepatectomy?" Ann Surg. 2019 03; 269(3):e33-e34.
    View in: PubMed
    Score: 0.088
  14. Sandström P, Røsok BI, Sparrelid E, Larsen PN, Larsson AL, Lindell G, Schultz NA, Bjørnbeth BA, Isaksson B, Rizell M, Björnsson B. Response to "ALPPS Versus Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastases". Ann Surg. 2019 01; 269(1):e16-e17.
    View in: PubMed
    Score: 0.087
  15. Sandström P, Rösok BI, Sparrelid E, Lindell G, Larsen PN, Larsson AL, Schultz NA, Isaksson B, Rizell M, Björnsson B. Response: "Unresectable Colorectal Liver Metastases: When Definitions Matter to Appropriately Assess Extreme Liver Resection Techniques". Ann Surg. 2018 12; 268(6):e83-e85.
    View in: PubMed
    Score: 0.087
  16. Hasselgren K, Sandström P, Røsok BI, Sparrelid E, Lindell G, Larsen PN, Larsson AL, Schultz NA, Björnbeth BA, Isaksson B, Rizell M, Björnsson B. Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion : FLR Increase in Patients with CRLM Is Highest the First Week After PVO. J Gastrointest Surg. 2019 03; 23(3):556-562.
    View in: PubMed
    Score: 0.087
  17. Sandström P, Røsok BI, Sparrelid E, Larsen PN, Larsson AL, Lindell G, Schultz NA, Bjørnbeth BA, Isaksson B, Rizell M, Björnsson B. ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial). Ann Surg. 2018 05; 267(5):833-840.
    View in: PubMed
    Score: 0.083
  18. Björnsson B, Sparrelid E, Røsok B, Pomianowska E, Hasselgren K, Gasslander T, Bjørnbeth BA, Isaksson B, Sandström P. Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results. Eur J Surg Oncol. 2016 Apr; 42(4):531-7.
    View in: PubMed
    Score: 0.071
  19. Spelt L, Sparrelid E, Isaksson B, Andersson RG, Sturesson C. Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases. HPB (Oxford). 2015 Jun; 17(6):529-35.
    View in: PubMed
    Score: 0.067
  20. Røsok BI, Björnsson B, Sparrelid E, Hasselgren K, Pomianowska E, Gasslander T, Bjørnbeth BA, Isaksson B, Sandström P. Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure. Surgery. 2016 May; 159(5):1279-86.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)